- Home
- SRPT vs SLG Comparison
SRPT vs SLG Comparison
Compare SRPT & SLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRPT | SLG |
|---|---|---|
| Founded | 1980 | 1980 |
| Country | United States | United States |
| Employees | N/A | 1289 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.6B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | SRPT | SLG |
|---|---|---|
| Price | $22.04 | $38.45 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 28 | 19 |
| Target Price | $25.40 | ★ $50.58 |
| AVG Volume (30 Days) | ★ 3.2M | 1.1M |
| Earning Date | 05-05-2026 | 04-15-2026 |
| Dividend Yield | N/A | ★ 8.23% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,198,237,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.58 | N/A |
| 52 Week Low | $10.42 | $34.77 |
| 52 Week High | $64.80 | $66.91 |
Technical Indicators
Market Signals| Indicator | SRPT | SLG |
|---|---|---|
| Relative Strength Index (RSI) | 60.58 | 52.01 |
| Support Level | $20.61 | $35.66 |
| Resistance Level | $23.51 | $40.63 |
| Average True Range (ATR) | 1.43 | 1.68 |
| MACD | 0.41 | 0.23 |
| Stochastic Oscillator | 77.43 | 69.59 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
About SLG SL Green Realty Corp
SL Green Realty is one of the largest Manhattan property owners and landlords, with interest in around 32 million square feet of wholly owned and joint-venture office space. The company has additional property exposure through its limited portfolio of well-located retail space. It operates as a real estate investment trust.